Determining therapeutic approaches in the elderly with rectal cancer

Drugs and Aging

Volumn 24, Issue 9, 2007, Pages 781-790

  Pasetto, Lara Maria ^a   Basso, Umberto ^a   Friso, Maria Luisa ^a   Pucciarelli, Salvatore ^b   Agostini, Marco ^b   Rugge, Massimo ^a   Sinigaglia, Giulietta ^c   Lise, Mario ^b   Sotti, Guido ^a   Monfardini, Silvio ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; RECTUM CANCER; SCORING SYSTEM;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PATIENT COMPLIANCE; PATIENT SELECTION; RADIOTHERAPY; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34548481780     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200724090-00006     Document Type: Article

References (35)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics 1999. Cancer J Clin 1999; 49: 8-31
2. Walter LC, Corvinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750-6
3. Jessup JM, McGinnis LS, Steele GD, et al. The National Cancer Data Base: report on colon cancer. Cancer 1996; 78: 918-26
4. Kohne H, Grothey A, Bekemeyer C, et al. Chemotherapy in elderly patients with colorectal cancer. Ann Oncol 2001; 12: 435-42
5. Grobovsky L, Kaplon M, Krozser-Hamati A, et al. Features of cancer in frail elderly patients (pts) (85 years of age) [abstract no. 2469]. Proc Am Soc Clin Oncol 2000; 18: 139
6. Rodel C, Grabenbauer GG, Shick C, et al. Preoperative radiation with concurrent 5-fluorouracil for locally-advanced T4 primary rectal cancer. Strahlenther Onkol 2000; 176: 161-7
7. Videtic GM, Fisher BJ, Perera FE, et al. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42 (2): 319-24
8. Chan AK, Wong AO, Langevin J, et al. Preoperative CT and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. Int J Radiat Oncol Biol Phys 2000; 48 (3): 843-56
9. Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001; 49: 987-95
10. Valentini V, Coco C, Cellinin N, et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001; 51: 371-83
11. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in gero-psychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41: 237-48
12. Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998; 16 (4): 1582-7
13. Firat S, Pleister A, Byhardt RW, et al. Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). Am J Clin Oncol 2006; 29 (3): 252-7
14. Firat S, Byhardt RW, Gore E. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 2002; 54 (2): 357-64
15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (5): 373-83
16. Ekberg L, Holmberg O, Wittgren L, et al. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol 1998 Jul; 48 (1): 71-7
17. Withers HR, Taylor JM, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 1988 Apr; 14 (4): 751-9
18. Enker EW, Thaler TH, Cranon LM, et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-46
19. AJCC American Joint Committee on Cancer. In: Fleming DI, Cooper SJ, Henson ED, et al., editors. AJCC cancer staging manual. 5th ed. Philadelphia (PA): Lippincott-Raven, 1997: 83-90
20. Kaplan EL, Meier P. Non parametric estimation for incomplete observation. J Am Stat Assoc 1958; 53: 457-81
21. Common terminology criteria for adverse events: version 3.0 (CTCAE), 2003 March 31. Publish date: August 9, 2006 [online]. Available from URL: http://ctep.cancer.gov/forms/CTCAEv3.pdf [Accessed 2007 Aug 14]
22. Popescu RA, Norman A, Ross PJ, et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol 1999; 17 (8): 2412-8
23. Chiara S, Nobile MT, Vincenti M, et al. Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy. Cancer Chemother Pharmacol 1998; 42 (4): 336-40
24. Stein BN, Petrelli NJ, Douglass HO, et al. Age and sex are independent predictors of 5-FU toxicity: analysis of a large scale phase III trial. Cancer 1995; 75: 11-7
25. Gómez H, Mas L, Casanova L, et al. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing haematologic toxicity. J Clin Oncol 1998; 16: 2352-8
26. Lyman GH, Kuderer NM, Balducci L. Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patients. Curr Opin Hematol 2002; 9: 207-14
27. Repetto L, Biganzoli L, Koehne CH, et al. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 2003; 39 (16): 2264-72
28. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 2004; 100 (2): 228-37
29. Lyman GH, Kuderer N, Agboola O, et al. Evidence-based use of colony-stimulating factors in elderly cancer patients. Cancer Control 2003; 10 (6): 487-99
30. Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 2000; 35 (3): 147-54
31. Chiappa A, Zbar AP, Bertani E, et al. Surgical outcomes for colorectal cancer patients including the elderly. Hepatogastroenterology 2001; 48 (38): 440-4
32. Audisio RA, Bozzetti F, Gennari R, et al. The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer 2004; 40 (7): 926-38
33. Ramesh HS, Jain S, Audisio RA. Implications of aging in surgical oncology. Cancer J 2005; 11 (6): 488-94
34. Kiran RP, Pokala N, Dudrick SJ. Long-term outcome after operative intervention for rectal cancer in patients aged over 80 years: analysis of 9,501 patients. Dis Colon Rectum 2007; 50 (5): 604-10
35. Shahir MA, Lemmens VE, van de Poll-Franse LV, et al. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 2006; 42 (17): 3015-21